Matches in SemOpenAlex for { <https://semopenalex.org/work/W1945764503> ?p ?o ?g. }
- W1945764503 endingPage "237" @default.
- W1945764503 startingPage "228" @default.
- W1945764503 abstract "With 10+ years follow-up in the Leukaemia Research Fund (LRF) CLL4 trial, we report the effect of salvage therapy, and the clinical/biological features of the 10-year survivors treated for chronic lymphocytic leukaemia (CLL). Overall survival (OS) was similar in the three randomized arms. With fludarabine-plus-cyclophosphamide (FC), progression-free survival (PFS) was significantly longer (P < 0.0001), but OS after progression significantly shorter, than in the chlorambucil or fludarabine arms (P < 0.0001). 614/777 patients progressed; 524 received second-line and 260 third-line therapy, with significantly better complete remission (CR) rates compared to first-line in the chlorambucil arm (7% vs. 13% after second-, 18% after third-line), but worse in the FC arm (38% vs. 15% after both second and third-line). OS 10 years after progression was better after a second-line CR versus a partial response (36% vs. 16%) and better with FC-based second-line therapy (including rituximab in 20%) or a stem cell transplant (28%) versus all other treatments (10%, P < 0.0001). The 176 (24%) 10-year survivors tended to be aged <70 years, with a good risk prognostic profile, stage A-progressive, achieving at least one CR, with a first-line PFS >3 years and receiving ≤2 lines of treatment. In conclusion, clinical/biological features and salvage treatments both influence the long-term outcome. Second-line therapies that induce a CR can improve OS in CLL patients." @default.
- W1945764503 created "2016-06-24" @default.
- W1945764503 creator A5031710371 @default.
- W1945764503 creator A5051208373 @default.
- W1945764503 creator A5090012595 @default.
- W1945764503 creator A5090938450 @default.
- W1945764503 date "2015-10-12" @default.
- W1945764503 modified "2023-10-09" @default.
- W1945764503 title "The long‐term outcome of patients in the <scp>LRF CLL</scp> 4 trial: the effect of salvage treatment and biological markers in those surviving 10 years" @default.
- W1945764503 cites W2009009231 @default.
- W1945764503 cites W2010779916 @default.
- W1945764503 cites W2015299436 @default.
- W1945764503 cites W2062373072 @default.
- W1945764503 cites W2063511774 @default.
- W1945764503 cites W2066564017 @default.
- W1945764503 cites W2084952484 @default.
- W1945764503 cites W2088580309 @default.
- W1945764503 cites W2095913486 @default.
- W1945764503 cites W2106033763 @default.
- W1945764503 cites W2108206643 @default.
- W1945764503 cites W2112937953 @default.
- W1945764503 cites W2117648265 @default.
- W1945764503 cites W2120319857 @default.
- W1945764503 cites W2125134816 @default.
- W1945764503 cites W2127516056 @default.
- W1945764503 cites W2140606816 @default.
- W1945764503 cites W2141883873 @default.
- W1945764503 cites W2146523291 @default.
- W1945764503 cites W2151177887 @default.
- W1945764503 cites W2163923077 @default.
- W1945764503 cites W2169269721 @default.
- W1945764503 cites W2172242534 @default.
- W1945764503 cites W2323897083 @default.
- W1945764503 cites W2522942571 @default.
- W1945764503 cites W4376595664 @default.
- W1945764503 doi "https://doi.org/10.1111/bjh.13824" @default.
- W1945764503 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4832371" @default.
- W1945764503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26457986" @default.
- W1945764503 hasPublicationYear "2015" @default.
- W1945764503 type Work @default.
- W1945764503 sameAs 1945764503 @default.
- W1945764503 citedByCount "11" @default.
- W1945764503 countsByYear W19457645032016 @default.
- W1945764503 countsByYear W19457645032017 @default.
- W1945764503 countsByYear W19457645032018 @default.
- W1945764503 countsByYear W19457645032019 @default.
- W1945764503 countsByYear W19457645032020 @default.
- W1945764503 countsByYear W19457645032021 @default.
- W1945764503 countsByYear W19457645032023 @default.
- W1945764503 crossrefType "journal-article" @default.
- W1945764503 hasAuthorship W1945764503A5031710371 @default.
- W1945764503 hasAuthorship W1945764503A5051208373 @default.
- W1945764503 hasAuthorship W1945764503A5090012595 @default.
- W1945764503 hasAuthorship W1945764503A5090938450 @default.
- W1945764503 hasBestOaLocation W19457645031 @default.
- W1945764503 hasConcept C126322002 @default.
- W1945764503 hasConcept C141071460 @default.
- W1945764503 hasConcept C143998085 @default.
- W1945764503 hasConcept C2776694085 @default.
- W1945764503 hasConcept C2776755627 @default.
- W1945764503 hasConcept C2777866208 @default.
- W1945764503 hasConcept C2777938653 @default.
- W1945764503 hasConcept C2778461978 @default.
- W1945764503 hasConcept C2779263901 @default.
- W1945764503 hasConcept C2779338263 @default.
- W1945764503 hasConcept C2780653079 @default.
- W1945764503 hasConcept C2780739268 @default.
- W1945764503 hasConcept C2780775027 @default.
- W1945764503 hasConcept C3019894029 @default.
- W1945764503 hasConcept C71924100 @default.
- W1945764503 hasConcept C90924648 @default.
- W1945764503 hasConceptScore W1945764503C126322002 @default.
- W1945764503 hasConceptScore W1945764503C141071460 @default.
- W1945764503 hasConceptScore W1945764503C143998085 @default.
- W1945764503 hasConceptScore W1945764503C2776694085 @default.
- W1945764503 hasConceptScore W1945764503C2776755627 @default.
- W1945764503 hasConceptScore W1945764503C2777866208 @default.
- W1945764503 hasConceptScore W1945764503C2777938653 @default.
- W1945764503 hasConceptScore W1945764503C2778461978 @default.
- W1945764503 hasConceptScore W1945764503C2779263901 @default.
- W1945764503 hasConceptScore W1945764503C2779338263 @default.
- W1945764503 hasConceptScore W1945764503C2780653079 @default.
- W1945764503 hasConceptScore W1945764503C2780739268 @default.
- W1945764503 hasConceptScore W1945764503C2780775027 @default.
- W1945764503 hasConceptScore W1945764503C3019894029 @default.
- W1945764503 hasConceptScore W1945764503C71924100 @default.
- W1945764503 hasConceptScore W1945764503C90924648 @default.
- W1945764503 hasFunder F4320319985 @default.
- W1945764503 hasFunder F4320320215 @default.
- W1945764503 hasIssue "2" @default.
- W1945764503 hasLocation W19457645031 @default.
- W1945764503 hasLocation W19457645032 @default.
- W1945764503 hasLocation W19457645033 @default.
- W1945764503 hasLocation W19457645034 @default.
- W1945764503 hasOpenAccess W1945764503 @default.
- W1945764503 hasPrimaryLocation W19457645031 @default.
- W1945764503 hasRelatedWork W2023984538 @default.
- W1945764503 hasRelatedWork W2044556191 @default.